Tannock LR - Search Results

1

Reversibility of renal injury with cholesterol lowering in hyperlipidemic diabetic mice.

Taneja D, Thompson J, Wilson P, Brandewie K, Schaefer L, Mitchell B, Tannock LR. Taneja D, et al. Among authors: tannock lr. J Lipid Res. 2010 Jun;51(6):1464-70. doi: 10.1194/jlr.M002972. Epub 2010 Jan 28. J Lipid Res. 2010. PMID: 20110440 Free PMC article.

2

Regulation of vascular proteoglycan synthesis by metabolic factors associated with diabetes.

Wilson P, Drennon K, Tannock LR. Wilson P, et al. Among authors: tannock lr. J Investig Med. 2007 Jan;55(1):18-25. doi: 10.2310/6650.2007.05067. J Investig Med. 2007. PMID: 17441408

3

Angiotensin II increases vascular proteoglycan content preceding and contributing to atherosclerosis development.

Huang F, Thompson JC, Wilson PG, Aung HH, Rutledge JC, Tannock LR. Huang F, et al. Among authors: tannock lr. J Lipid Res. 2008 Mar;49(3):521-30. doi: 10.1194/jlr.M700329-JLR200. Epub 2007 Nov 21. J Lipid Res. 2008. PMID: 18033753 Free article.

4

Advances in the management of hyperlipidemia-induced atherosclerosis.

Tannock LR. Tannock LR. Expert Rev Cardiovasc Ther. 2008 Mar;6(3):369-83. doi: 10.1586/14779072.6.3.369. Expert Rev Cardiovasc Ther. 2008. PMID: 18327996 Review.

5

Serum amyloid A, but not C-reactive protein, stimulates vascular proteoglycan synthesis in a pro-atherogenic manner.

Wilson PG, Thompson JC, Webb NR, de Beer FC, King VL, Tannock LR. Wilson PG, et al. Among authors: tannock lr. Am J Pathol. 2008 Dec;173(6):1902-10. doi: 10.2353/ajpath.2008.080201. Epub 2008 Oct 30. Am J Pathol. 2008. PMID: 18974302 Free PMC article.

6

Managing highly insulin-resistant diabetes mellitus: weight loss approaches and medical management.

Brown A, Desai M, Taneja D, Tannock LR. Brown A, et al. Among authors: tannock lr. Postgrad Med. 2010 Jan;122(1):163-71. doi: 10.3810/pgm.2010.01.2110. Postgrad Med. 2010. PMID: 20107300 Review.

7

Clinical efficacy and patient satisfaction with U-500 insulin use.

Dailey AM, Williams S, Taneja D, Tannock LR. Dailey AM, et al. Among authors: tannock lr. Diabetes Res Clin Pract. 2010 Jun;88(3):259-64. doi: 10.1016/j.diabres.2010.02.012. Epub 2010 Mar 11. Diabetes Res Clin Pract. 2010. PMID: 20226557 Free PMC article.

8

Renal accumulation of biglycan and lipid retention accelerates diabetic nephropathy.

Thompson J, Wilson P, Brandewie K, Taneja D, Schaefer L, Mitchell B, Tannock LR. Thompson J, et al. Among authors: tannock lr. Am J Pathol. 2011 Sep;179(3):1179-87. doi: 10.1016/j.ajpath.2011.05.016. Epub 2011 Jun 30. Am J Pathol. 2011. PMID: 21723246 Free PMC article.

9

Serum amyloid A in atherosclerosis.

King VL, Thompson J, Tannock LR. King VL, et al. Among authors: tannock lr. Curr Opin Lipidol. 2011 Aug;22(4):302-7. doi: 10.1097/MOL.0b013e3283488c39. Curr Opin Lipidol. 2011. PMID: 21734573 Review.

10

Decreased body fat, elevated plasma transforming growth factor-β levels, and impaired BMP4-like signaling in biglycan-deficient mice.

Tang T, Thompson JC, Wilson PG, Nelson C, Williams KJ, Tannock LR. Tang T, et al. Among authors: tannock lr. Connect Tissue Res. 2013;54(1):5-13. doi: 10.3109/03008207.2012.715700. Epub 2012 Aug 23. Connect Tissue Res. 2013. PMID: 22834985 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

81 results

Search Page

Filters